Phone: Thought Leadership
The Continuously Increasing Value of Medical Affairs in Product Launches – Part I
AUTHOR: N. Borinshteyn
Bringing each new pharmaceutical product to market is a complex and somewhat unique process led and executed by a cross-functional team who undertakes a number…CONTINUE READING
Case for an IT-enabling Business Strategy for companies in the Life Sciences Industry
AUTHOR: D. Douglas
The major trends in the life sciences industry are profoundly affecting the way we all work – from conducting research to distributing products, and everything…CONTINUE READING
The Value of an Integrated Launch Plan
AUTHOR: CMK SELECT
There is only one opportunity to successfully launch a pharmaceutical brand. Brand leaders must navigate pitfalls and obstacles by planning, coordinating, and executing a comprehensive…CONTINUE READING
The Rising Value of Medical Affairs
AUTHOR: N. Borinshteyn
It’s not news that market pressures are driving the healthcare industry’s increasing medical orientation. Recognized trends that are leading this shift include: Growing prevalence of…CONTINUE READING
Ensuring Launch Success with KPIs
AUTHOR: D. Yerranguntla
KPIs, or key performance indicators, are critical to the success of a pharmaceutical product launch. By their very definition, KPIs are measurable values that demonstrate…CONTINUE READING
Value Pricing in the Life Sciences Industry
AUTHOR: CMK SELECT
Value pricing is taking the life sciences industry by storm, providing an opportunity to create goodwill with customers and positive brand recognition. More and more…CONTINUE READING
CMK Select Recognized as an NJBIZ Fast 50 Award Winner
AUTHOR: CMK SELECT
CMK Select is honored to be recognized for our dynamic growth this year by NJBIZ, New Jersey’s leading business journal publication, as an NJBIZ Fast…CONTINUE READING
Planning for Launch Success
AUTHOR: CMK SELECT
There are many ways to measure how successful a product launch really is. With over 60 launches under our belt in the pharmaceutical industry, at…CONTINUE READING
Five Common Barriers to Optimal Launch Trajectory (Part 2 of 2)
AUTHOR: B.Turakhia
Fifty percent of new drug launches do not achieve peak sales, with half of them missing their targeted goals by 50% or more.1 How can…CONTINUE READING
Five Common Barriers to Optimal Launch Trajectory (Part 1)
AUTHOR: B.Turakhia
New Drug Launch, Day 1… The most anticipated and pivotal day for a pharmaceutical company. It takes an average of 14 years and $2.6 billion…CONTINUE READING